API
< Back to situations

[ORGANIZATION]

GLP-1 receptor agonists

Featured in 17 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [GB] [SE]

Expanding therapeutic uses and regulatory concerns for GLP-1

43 clusters · 183 sources · last updated

Latest: Semaglutide shows efficacy in treating obesity in children aged 6 to 11

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

342 clusters · 1316 sources · last updated

Latest: GLP-1 medications linked to diverse health outcomes and access challenges

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt

[ACTIVE] [HEALTH] [US] [BR] [DE]

GLP-1 receptor agonist research and safety scrutiny

13 clusters · 72 sources · last updated

Latest: FDA requires GLP-1 medication warnings for rare eye condition

Research into GLP-1 receptor agonists (GLP-1 RAs) continues to expand, investigating benefits beyond glycemic control and weight loss. Potential advantages include cardiovascular protection, kidney support, reduction in

Also covered in